WMB to Acquire Bakken Shale Assets Monday, November 15, 12:02 PM ET, by Market News Video Staff Williams Companies (WMB) said today it has agreed to acquire 85,800 acres from private owners ...
CCJ to Supply Chinese Nuclear Company with Uranium Wednesday, November 24, 12:57 PM ET, by Market News Video Staff Cameco (CCJ) said today it had agreed to supply China Guangdong Nuclear Power Holding Co. ...
Bearish Two Hundred Day Moving Average Cross - EBS Tuesday, May 24, 1:59 PM ET, by Market News Video Staff In trading on Tuesday, shares of Emergent BioSolutions Inc (EBS) crossed below their 200 day ...
KERX Crosses Below Key Moving Average Level Friday, June 10, 4:16 PM ET, by Market News Video Staff In trading on Friday, shares of Keryx Biopharmaceuticals Inc. (KERX) crossed below their 200 day ...
Bargain Hunters Take Note: Insider Cluster-Buying At OREX
By Market News Video Staff, Friday, December 23, 10:49 AM ET
A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At Orexigen Therapeutics, Inc. (NASDAQ:OREX), 8 different insiders purchased 3,284,029 shares at an average price of $1.45/share, for a total of $4.76M, with the most recent purchase on December 22, 2011.
Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money. So when multiple insiders all decide to make purchases around the same time, it could be a strong indication that the stock is undervalued. Below is a table summarizing the insider buys that make up this "cluster":
Purchased
Insider
Title
Shares
Price/Share
Value
12/22/2011
Brian K. Halak
469,147
$1.45
$680,263.15
12/22/2011
Brian H. Dovey
Director
469,147
$1.45
$680,263.15
12/22/2011
Vii Associates LP DP
7,882
$1.45
$11,428.90
12/22/2011
Parters Vii L. P. Domain
461,265
$1.45
$668,834.25
12/22/2011
James C. Blair
469,147
$1.45
$680,263.15
12/22/2011
Nicole Vitullo
469,147
$1.45
$680,263.15
12/22/2011
Kathleen K. Schoemaker
469,147
$1.45
$680,263.15
12/22/2011
Jesse I. Treu
469,147
$1.45
$680,263.15
The chart below shows the one year performance of OREX shares, versus its 200 day moving average. Note that OREX's low point in its 52 week range is $1.22 per share, with $10.08 as the 52 week high point — that compares with a last trade of $1.59, with shares currently trading trading flat on the day.
OREX operates in the Biotechnology sector, among companies like Exelixis Inc (NASDAQ:EXEL) which is down about 1.9% today, and Emergent BioSolutions Inc (NYSE:EBS) trading higher by about 0.1%. Below is a three month price history chart comparing the stock performance of OREX, versus EXEL and EBS.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:BelowBrianDirectorEXELInvestmentNASDAQOREXValueaboutallowsaroundassetaveragecallcashchartclustercompanycompletelycurrentlydecidedesigneddifferentgrowthinsiderinsidersmakemarketmostopenperformancepointportfoliopricepurchasessharesharesshortstockstrongtablethattheirthisthreetradingversusweekwhenwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.